These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1792854)

  • 1. Continuous intravenous infusion of TRH-T: clinical, cardiovascular and endocrinological effects.
    Formisano R; Ruggieri S; Cerbo R; Lucarelli F; De Vuono G; Parmegiani M; Agnoli A; Attanasio A; Capria A; Piccolo CG
    Acta Neurol Scand; 1991 Dec; 84(6):514-8. PubMed ID: 1792854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
    Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
    Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration.
    Brooks BR; Kalin N; Beaulieu DA; Barksdale C; Sufit RL; Dills DG
    Neurol Res; 1988 Dec; 10(4):236-8. PubMed ID: 2907112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous thyrotropin releasing hormone in amyotrophic lateral sclerosis: autonomic effects.
    Beaulieu DA; Erickson L; Williams A; Sufit RL; Brooks BR
    Neurol Clin; 1987 May; 5(2):269-90, vi. PubMed ID: 11681403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of TRH in amyotrophic lateral sclerosis and in other neurological diseases.
    Congia S; Tronci S; Ledda M; Porcella A; Coppola G
    Ital J Neurol Sci; 1991 Apr; 12(2):193-8. PubMed ID: 1906441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: experience with an intrathecal drug delivery system.
    Munsat TL; Taft J; Jackson IM; Andres PL; Hollander D; Skerry L; Ordman M; Kasdon D; Finison L
    Neurology; 1992 May; 42(5):1049-53. PubMed ID: 1579228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a continuous thyrotropin-releasing hormone infusion on gonadotropin-releasing hormone-stimulated gonadotropin secretion.
    McDermott MT; Sjoberg RJ; Hofeldt FD; Kidd GS
    J Lab Clin Med; 1990 Aug; 116(2):187-90. PubMed ID: 2118558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).
    Yamane K; Osawa M; Kobayashi I; Maruyama S
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):179-87. PubMed ID: 3097367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of pulsatile and continuous TRH infusion on TSH release in men.
    Hartnell JM; Pekary AE; Hershman JM
    Metabolism; 1987 Sep; 36(9):878-82. PubMed ID: 3114594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
    Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA
    Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.